Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: II. Dense spontaneous echocardiographic contrast (The stroke prevention in atrial fibrillation [SPAF-III] study)

Journal of the American Society of Echocardiography

Volumn 12, Issue 12, 1999, Pages 1088-1096

  Asinger, R W ^a   Koehler, J ^a   Pearce, L A ^a   Zabalgoitia, M ^a   Blackshear, J L ^a   Fenster, P E ^a   Strauss, R ^a   Hess, D ^a   Pennock, G D ^a   Rothbart, R M ^a   Halperin, J L ^a  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN;

ADULT; AGE; AGED; ANATOMY; AORTA ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONFERENCE PAPER; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART VOLUME; HEMODYNAMICS; HEMOSTASIS; HUMAN; HYPERTENSION; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; RISK ASSESSMENT; STROKE;

EID: 0032803662     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0894-7317(99)70106-9     Document Type: Conference Paper

References (41)

1. FL Mikell RW Asinger KJ Elsperger Regional stasis of blood in the dysfunctional left ventricle: echocardiographic detection and differentiation from early thrombosis Circulation 66 1982 755 763
2. WG Daniel U Neilessen E Schroder Left atrial spontaneous echo contrast in mitral valve disease: an indicator for an increased thromboembolic risk J Am Coll Cardiol 11 1988 1204 1211
3. R Castello AC Pearson AJ Labovitz Prevalence and clinical implications of atrial spontaneous contrast in patients undergoing transesophageal echocardiography Am J Cardiol 65 1990 1149 1153
4. JJ Hwang FN Ko YH Li Clinical implications and factors related to left atrial spontaneous echo contrast in chronic nonvalvular atrial fibrillation Cardiology 85 1994 69 72
5. GA Pop HJ Meeder JR Roelandt Transthoracic echo/doppler in the identification of patients with chronic non-valvular atrial fibrillation at risk for thromboembolic events Eur Heart J 15 1994 1545 1551
6. A Mugge H Kuhn P Nikutta Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: identification of a subgroup of patients at increased embolic risk J Am Coll Cardiol 23 1994 599 607
7. YH Li LP Lai KG Shyu Clinical implications of left atrial appendage flow patterns in nonrheumatic atrial fibrillation Chest 105 1994 748 752
8. R Mitusch V Lange U Stierle Transesophageal echocardiographic determinants of embolism in nonrheumatic atrial fibrillation Int J Cardiac Imaging 11 1995 27 34
9. IW Black CN Chesterman AP Hopkins Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation J Am Coll Cardiol 21 1993 451 457
10. Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography Transesophageal echocardiography in atrial fibrillation: standards for acquisition and interpretation and assessment of inter-observer variability J Am Soc Echocardiogr 9 1996 556 566
11. Stroke Prevention in Atrial Fibrillation Investigators, Committee on Echocardiography Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation Ann Intern Med 128 1998 639 647
12. M Zabalgoitia JL Halperin LA Pearce JL Blackshear RW Asinger RG Hart Transesophageal Echocardiographic Correlates of Clinical Risk of Thromboembolism in Nonvalvular Atrial Fibrillation J Am Coll Cardiol 31 1998 1622 1626
13. Stroke Prevention in Atrial Fibrillation Investigators Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk Ann Intern Med 116 1992 1 5
14. Stroke Prevention in Atrial Fibrillation Investigators Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk Ann Intern Med 116 1992 6 12
15. Atrial Fibrillation Investigators Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials Arch Intern Med 154 1994 1449 1457
16. Stroke Prevention in Atrial Fibrillation Investigators The Stroke Prevention in Atrial Fibrillation III randomized clinical trial: background, design and patient characteristics J Stroke Cerebrovasc Dis 6 1997 341 353
17. Stroke Prevention in Atrial Fibrillation Investigators The Stroke Prevention in Atrial Fibrillation Study: final Results Circulation 84 1991 527 539
18. Stroke Prevention in Atrial Fibrillation Investigators Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study Lancet 343 1994 687 691
19. Stroke Prevention in Atrial Fibrillation Investigators Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial Lancet 348 1996 633 638
20. DJ Sahn A DeMaria J Kisslo A Weyman Recommendations regarding quantitation of M-mode echocardiography: results of a survey of echocardiographic measurements Circulation 58 1978 1072 1083
21. NB Schiller PM Shah M Crawford Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms J Am Soc Echocardiogr 2 1989 358 367
22. PC Come MF Riley M-mode and cross-sectional echocardiographic recognition of fibrosis and calcification of the mitral valve chordae and left ventricular papillary muscle Am J Cardiol 49 1982 461 466
23. W Aschenberg M Schluter P Kremer Transesophageal two-dimensional echocardiography for the detection of left atrial appendage thrombus J Am Coll Cardiol 7 1986 163 166
24. DG Karalis K Chandrasekaran MK Victor Recognition and embolic potential of intra-aortic atherosclerotic debris J Am Coll Cardiol 17 1991 73 78
25. PA Tunick JL Perez I Kronzon Protruding atheromas in the thoracic aorta and systemic embolization Ann Intern Med 115 1991 423 427
26. P Amarenco C Duyckaerts C Tzourio The prevalence of ulcerated plaques in the aortic arch in patients with stroke N Engl J Med 326 1992 221 225
27. A Clauss Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens Acta Haematologica 17 1957 237 246
28. C Stollberger P Chnupa G Kronik for the ELAT Study Group. Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation Ann Intern Med 128 1998 630 638
29. B Sigel JC Coelho DC Soigos Ultrasonography of blood during stasis and coagulation Invest Radiol 16 1981 71 76
30. YW Yuan KK Shung Ultrasonic backscatter from flowing whole blood. I. Dependence on shear rate and hematocrit J Acoust Soc Am 84 1988 52 58
31. YW Yuan KK Shung Ultrasonic backscatter from flowing whole blood. II. Dependence on frequency and fibrinogen concentration J Acoust Soc Am 84 1988 1195 1200
32. A Merino P Hauptman L Badimon Echocardiographic “smoke” is produced by an interaction of erythrocytes and plasma proteins modulated by shear forces J Am Coll Cardiol 20 1992 1661 1668
33. D Santiago M Warshofsky G LiMandri Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: a transesophageal echocardiographic study J Am Coll Cardiol 24 1994 159 164
34. C Pollick D Taylor Assessment of left atrial appendage function by transesophageal echocardiography: implications for the development of thrombus Circulation 84 1991 223 231
35. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology Guidelines for prevention of thromboembolic events in valvular heart disease Eur Heart J 16 1995 1320 1330
36. JJ Hwang KG Shyu KL Hsu Significant mitral regurgitation is protective against left atrial spontaneous echo contrast formation, but not against systemic embolism Chest 106 1994 8 12
37. CM Movsowitz HD Movsowitz LE Jacobs Significant mitral regurgitation is protective against left atrial spontaneous echo contrast and thrombus as assessed by transesophageal echocardiography J Am Soc Echocardiogr 6 1993 107 114
38. JL Blackshear LA Pearce RW Asinger for the Stroke Prevention in Atrial Fibrillation Investigators. Mitral regurgitation associated with reduced thromboembolic events in high risk patients with atrial fibrillation Am J Cardiol 72 1993 840 843
39. GYH Lip GDO Lowe A Rumley FG Dunn Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin therapy Br Heart J 73 1995 527 533
40. GYH Lip GDO Lowe A Rumley FG Dunn Fibrinogen and fibrin d-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis Am Heart J 131 1996 724 730
41. H Sandler HT Dodge The use of single-plane angiocardiograms for the calculation of left ventricular volume in man Am Heart J 75 1968 325 334